Search alternatives:
significant interaction » significant reduction (Expand Search), significant attention (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
interaction decrease » intervention decreases (Expand Search), interaction terms (Expand Search), interaction dataset (Expand Search)
significant interaction » significant reduction (Expand Search), significant attention (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
interaction decrease » intervention decreases (Expand Search), interaction terms (Expand Search), interaction dataset (Expand Search)
-
2501
-
2502
-
2503
Verification of PLUS CYCLE<sup>®</sup> signals during presumed sleep periods.
Published 2025Subjects: -
2504
-
2505
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2506
-
2507
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2508
-
2509
-
2510
-
2511
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2512
-
2513
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2514
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2515
-
2516
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2517
-
2518
-
2519
-
2520